Arooge Towheed, MD
Clinical Cardiac Electrophysiology · Largo, MDNPI 1588071930
Payments from drug & device makers
What this record shows
This record is dominated by grants: $44,000 of the $60,099 with a category attached, or 73.2%. Medtronic accounts for 69.7% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2020 at $34,091 and has fallen 96.9% since, to $1,068 in 2025.
Across 191 payments — averaging $314.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$42K
- Abbott$14K
- Philips North America LLC$1K
- Boston Scientific$984
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$513
- Biotronik Inc.$351
- plus $1K from 13 others
What the payments were for
- Grants$44,00073%
- Travel & lodging$9,76516%
- Food & beverage$6,09510%
- Education$2390%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 74 | $41,908 |
| Abbott | 18 | $13,907 |
| Philips North America LLC | 5 | $1,298 |
| Boston Scientific | 27 | $984 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 20 | $513 |
| Biotronik Inc. | 9 | $351 |
| Biosense Webster, Inc. | 7 | $249 |
| Medical Device Business Services, Inc. | 1 | $174 |
| Novartis | 6 | $151 |
| E.r. Squibb & Sons, L.L.C. | 6 | $126 |
| Novo Nordisk | 3 | $88 |
| Kestra Medical Technology Services, Inc. | 3 | $66 |
| Atricure, Inc. | 3 | $64 |
| AstraZeneca | 3 | $52 |
| Chiesi USA, Inc. | 1 | $46 |
| Pfizer | 2 | $45 |
| Cvrx, Inc. | 1 | $32 |
| Cardiva Medical, Inc. | 1 | $24 |
| Cordis US CORP. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVEIR$4,431
- Micra$1,344
- EVERA MRI XT DR SURESCAN$1,288
- (9124) LM Undivided$1,070
- WATCHMAN Access System$299
- Arctic Front$191
- Carto 3$174
- AMVIA EDGE$150
- PAMIRA$150
- Acticor 7 VR-T DX$150
- Selectra$150
- Solia$150
- IGT Devices Und$137
- Perclose ProGlide suture mediated closure system$113
- ENSITE PRECISION$113
How this compares
$60,099 in reported general payments places this provider in the 85th percentile of 63 clinical cardiac electrophysiology providers in Maryland.
See all clinical cardiac electrophysiology providers in Maryland →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 275 | $295,181 |
| XareltoRivaroxaban | 67 | $85,373 |
| EntrestoSacubitril/Valsartan | 36 | $47,662 |
| JardianceEmpagliflozin | 31 | $30,419 |
| MultaqDronedarone Hcl | 11 | $16,861 |
| FarxigaDapagliflozin Propanediol | 19 | $11,572 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 16 | $5,217 |
| Amiodarone Hcl | 175 | $4,428 |
| Flecainide Acetate | 105 | $3,218 |
| Metoprolol Succinate | 178 | $2,872 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 51 | $1,436 |
| Mexiletine Hcl | 17 | $1,252 |
| Valsartan | 18 | $1,017 |
| Dofetilide | 14 | $947 |
| Carvedilol | 50 | $854 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $45 | $295,181275 claims |
| NovartisEntresto | $151 | $47,66236 claims |
| AstraZenecaFarxiga | $52 | $11,57219 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 63 clinical cardiac electrophysiology providers in Maryland.
Other clinical cardiac electrophysiology in Largo
- Ian BarrowsLargo$24K
- Sean BeinartRockville$315K
- Charles LoveBaltimore$238K
- Hugh CalkinsBaltimore$202K
- Paresh ShahBaltimore$97K
- Helen BaroldRockville$83K
- Jonathan ChrispinBaltimore$77K
- Sung LeeTakoma Park$68K
- Stephen ShorofskyBaltimore$63K
- Nilofar IslamTowson$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.